US Healthcare & Medical Biotech / Medical Equipment - PPC Market Share Analysis March 2025

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Biotech / Medical Equipment category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Market Exposure

Share of Clicks for top 10 US Healthcare & Medical Biotech / Medical Equipment brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data

Share of Clicks - Last month
Domain	Share of clicks
cvs.com	7.26
23andme.com	5.85
cpap.com	5.07
amscope.com	3.24
lofta.com	2.64
biolifeplasma.com	2.3
clearchoice.com	2.29
uline.com	2.2
cslplasma.com	2.18
directhomemedical.com	2.01
others	64.96

In the PPC landscape, CVS leads with 7.26% click share, followed by 23andMe at 5.85%. CPAP.com captures 5.07%, while ‘others’ dominate with 64.96%.

Market Exposure

Share of Spend for the top 10 US Healthcare & Medical Biotech / Medical Equipment brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month.

See more data

Share of Spend - Last Month
Date	cpap.com	clearchoice.com	cvs.com	aspendental.com	lofta.com	nuviasmiles.com	uline.com	biolifeplasma.com	directhomemedical.com	23andme.com
2025/03/01	3.1%	4.34%	3.87%	1.52%	2.1%	1.63%	1.94%	1.8%	1.96%	4.12%
2025/03/02	3.28%	5.1%	3.71%	0.92%	2.26%	1.08%	1.41%	2.58%	1.45%	3.11%
2025/03/03	2.89%	5.14%	4.88%	1.78%	2.32%	1.04%	1.88%	2.62%	1.81%	3.78%
2025/03/04	3.41%	6.2%	4.79%	2.79%	2.16%	1.14%	1.75%	3.1%	2.06%	3.26%
2025/03/05	3.44%	6.52%	4.4%	3.71%	1.79%	2.33%	1.93%	2.23%	1.69%	2.89%
2025/03/06	2.9%	7.85%	4.52%	4.8%	1.94%	2.48%	1.33%	3.47%	1.26%	2.72%
2025/03/07	4.33%	5.82%	5.06%	3.2%	2.16%	2.53%	1.32%	3.09%	1.53%	2.27%
2025/03/08	4.27%	5.18%	5.1%	1.68%	2.48%	2.93%	1.07%	3.22%	2.1%	2.12%
2025/03/09	3.43%	5.37%	5.73%	0.84%	2.73%	2.06%	1.02%	2.09%	1.89%	2.49%
2025/03/10	4.06%	5.53%	4.34%	2.52%	2.23%	1.58%	1.63%	2.82%	1.25%	2%
2025/03/11	4.06%	3.59%	4.7%	2.1%	2.62%	0.67%	1.69%	2.88%	1.47%	2.77%
2025/03/12	3.12%	6.53%	4.16%	2.89%	2.38%	2.55%	2.05%	3.31%	1.34%	2.18%
2025/03/13	3.28%	6.71%	4.82%	4.17%	2.66%	2.13%	2.2%	2.61%	1.14%	2.11%
2025/03/14	3.19%	6.99%	4.12%	2.5%	2.3%	3.21%	1.66%	3.4%	1.43%	2.11%
2025/03/15	3.25%	6.58%	4.27%	1.05%	2.99%	2.62%	1.38%	3.48%	1.99%	2.56%
2025/03/16	2.62%	5.45%	4.77%	0.57%	3.1%	1.57%	1.42%	2.8%	1.83%	2.51%
2025/03/17	3.54%	5.67%	4.62%	2.07%	2.15%	1.76%	1.96%	2.88%	1.69%	1.43%
2025/03/18	3.32%	4.64%	3.74%	2.05%	1.75%	2.83%	2.12%	3.02%	1.97%	1.64%
2025/03/19	3.65%	5.5%	4.24%	1.95%	1.81%	2.25%	1.87%	2.82%	1.93%	1.85%
2025/03/20	4.94%	5.66%	4.47%	2.08%	2.21%	1.77%	1.93%	3.08%	1.81%	2.31%
2025/03/21	4.22%	6.21%	4.24%	2.95%	2.24%	2.78%	2.11%	2.88%	1.63%	2.19%
2025/03/22	3.48%	5.72%	3.87%	2.47%	2.4%	4.02%	1.02%	2.79%	1.86%	2.11%
2025/03/23	3.66%	4.56%	4.48%	0.49%	2.87%	1.53%	1.18%	2.17%	2.06%	2.37%
2025/03/24	4.12%	5.49%	3.67%	3.85%	2.18%	2.42%	2.13%	3.18%	1.68%	1.98%
2025/03/25	4.01%	6.11%	3.77%	4.41%	2.21%	1.49%	2.4%	3.01%	2.39%	1.72%
2025/03/26	4.12%	6.5%	3.6%	4.9%	2.48%	1.95%	2.17%	3.48%	2.18%	1.17%
2025/03/27	4.2%	6.37%	3.51%	3.36%	2.54%	2.75%	2.27%	3.33%	1.84%	0.76%
2025/03/28	3.9%	6.42%	3.82%	4.12%	2.1%	2.38%	2.53%	2.6%	1.76%	0.63%
2025/03/29	4.27%	7.75%	3.79%	1.7%	2.07%	2.2%	2.47%	2.34%	1.73%	1.01%
2025/03/30	5.16%	5.9%	4.32%	1.31%	2.51%	2.26%	1.92%	2.53%	1.83%	0.47%
2025/03/31	6.1%	4.71%	4.66%	3.68%	2.77%	2.08%	1.8%	1.69%	1.59%	0.84%

In March 2025, CPAP.com saw a steady rise, peaking at 6.10% on the 31st. ClearChoice.com fluctuated, ending at 4.71%. CVS.com maintained stability, closing at 4.66%. AspenDental.com experienced volatility, finishing at 3.68%. Lofta.com showed gradual growth, reaching 2.77%. NuviaSmiles.com had ups and downs, ending at 2.08%. Uline.com remained consistent, closing at 1.80%. BioLifePlasma.com saw a decline, finishing at 1.69%. DirectHomeMedical.com showed minor fluctuations, ending at 1.59%. 23andMe.com experienced a significant drop, closing at 0.84%.

Market Exposure

Competitor Count for US Healthcare & Medical Biotech / Medical Equipment

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month.

See more data

Competitor Count - Last month
Date	Competitor Count
2025/03/01	1837
2025/03/02	1881
2025/03/03	1940
2025/03/04	1916
2025/03/05	1922
2025/03/06	2140
2025/03/07	2102
2025/03/08	1990
2025/03/09	1790
2025/03/10	1965
2025/03/11	1857
2025/03/12	1901
2025/03/13	1866
2025/03/14	1872
2025/03/15	1668
2025/03/16	1730
2025/03/17	1709
2025/03/18	1764
2025/03/19	1775
2025/03/20	1716
2025/03/21	1779
2025/03/22	1816
2025/03/23	1710
2025/03/24	1744
2025/03/25	1686
2025/03/26	1805
2025/03/27	1753
2025/03/28	1755
2025/03/29	1676
2025/03/30	1705
2025/03/31	1794

March began with 1,837 advertisers, peaking at 2,140 on the 6th. A decline followed, reaching 1,668 on the 15th. The month concluded with a slight recovery to 1,794 advertisers.

Campaign Efficiency

Market Loss & Market Gains for US Healthcare & Medical Biotech / Medical Equipment

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data

Market Loss & Market Gains - Last month
Name	Market Trend
cpap.com	1.16%
uline.com	0.78%
cslplasma.com	0.74%
amscope.com	0.55%
resmed.com	0.51%
walgreens.com	-0.32%
thecpapshop.com	-0.39%
1800contacts.com	-0.42%
cvs.com	-0.96%
23andme.com	-3.24%

CPAP.com surged with a 1.16% click share increase, while 23andme.com faced a 3.24% decline.

Campaign Efficiency

US Healthcare & Medical Biotech / Medical Equipment Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data

Date	cvs.com	cpap.com	lofta.com	cpapx.com	uline.com	directhomemedical.com	amscope.com	clearchoice.com	biolifeplasma.com	23andme.com
2025/03/01	7.37%	2.99%	2.37%	3.02%	2.88%	2.59%	3.78%	1.64%	1.34%	4.46%
2025/03/02	7.69%	2.85%	2.75%	2.49%	1.98%	2.06%	3.31%	1.6%	1.91%	3.44%
2025/03/03	8.8%	2.25%	2.47%	2.24%	3%	2.34%	2.64%	1.77%	1.84%	4.41%
2025/03/04	8.81%	2.74%	2.31%	2.56%	2.56%	2.87%	2.25%	2.23%	2.2%	3.79%
2025/03/05	8.54%	3.03%	2.17%	2.33%	2.78%	2.39%	2.2%	2.54%	1.68%	3.63%
2025/03/06	8.55%	2.58%	2.41%	1.87%	2.37%	1.86%	1.53%	3.26%	2.54%	3.39%
2025/03/07	9.33%	3.49%	2.75%	2.24%	2.06%	2.19%	1.71%	2.36%	2.31%	2.94%
2025/03/08	9.91%	3.3%	2.94%	2.38%	1.31%	2.9%	1.55%	1.91%	2.51%	2.6%
2025/03/09	9.92%	2.74%	3.24%	2.83%	1.28%	2.43%	2.51%	2.01%	1.58%	2.78%
2025/03/10	8.17%	3.57%	2.88%	2.41%	2.29%	1.73%	2.28%	2.01%	2.18%	2.51%
2025/03/11	8.54%	3.37%	3.13%	2.7%	2.28%	1.92%	2.14%	1.29%	2.24%	3.28%
2025/03/12	8.19%	2.59%	2.71%	3.07%	3.12%	1.74%	1.61%	2.56%	2.47%	2.67%
2025/03/13	8.67%	2.67%	3.16%	2.35%	3.57%	1.61%	2.86%	2.68%	1.88%	2.61%
2025/03/14	7.8%	2.75%	2.9%	2.38%	2.38%	2%	2.21%	2.67%	2.6%	2.55%
2025/03/15	8.44%	2.57%	3.37%	2.08%	1.41%	2.73%	3.09%	2.25%	2.55%	3.16%
2025/03/16	8.85%	2.17%	3.78%	1.79%	1.61%	2.66%	2.12%	2.03%	1.96%	2.89%
2025/03/17	8.41%	3.09%	2.57%	2.26%	3.12%	2.28%	2%	2.15%	2.07%	1.73%
2025/03/18	7.4%	2.77%	2.1%	2.35%	3.68%	2.88%	1.45%	1.92%	2.23%	1.78%
2025/03/19	8.1%	3.13%	2.09%	2.03%	2.91%	2.82%	2.34%	2.14%	2.14%	2.25%
2025/03/20	8.27%	4.19%	2.42%	1.88%	2.81%	2.35%	2.89%	2.2%	2.2%	2.73%
2025/03/21	8.05%	3.53%	2.63%	2.57%	3.03%	2.26%	1.68%	2.45%	2.18%	2.73%
2025/03/22	7.17%	2.97%	2.77%	2.36%	1.21%	2.72%	2.86%	2.07%	2.04%	2.54%
2025/03/23	7.6%	2.9%	3.14%	2.8%	1.62%	2.63%	3.28%	1.59%	1.52%	2.79%
2025/03/24	6.87%	3.48%	2.55%	2.72%	3.39%	2.45%	3.08%	1.91%	2.38%	2.42%
2025/03/25	7.32%	3.48%	2.5%	2.88%	4.24%	3.37%	3.02%	2.42%	2.31%	2.03%
2025/03/26	7.21%	3.6%	2.94%	2.67%	3.93%	3.02%	2.35%	2.66%	2.56%	1.4%
2025/03/27	7.03%	3.91%	3.17%	2.77%	4.25%	2.83%	1.99%	2.53%	2.5%	1%
2025/03/28	7.49%	3.67%	2.71%	2.45%	4.98%	2.58%	2.27%	2.53%	2%	0.82%
2025/03/29	7.42%	3.55%	2.3%	2.48%	4.09%	2.4%	2.43%	3.04%	1.87%	1.27%
2025/03/30	8.14%	4.68%	3.08%	2.78%	3.21%	2.4%	1.81%	2.11%	1.75%	0.6%
2025/03/31	8.27%	5.06%	3.19%	3.05%	2.95%	2.18%	2.15%	1.79%	1.28%	0.97%

In March 2025, CVS.com led with fluctuating impressions, peaking mid-month. CPAP.com showed a steady rise, ending strong. Lofta.com and CPAPx.com had moderate gains. Uline.com surged late March. DirectHomeMedical.com remained stable. AmScope.com and ClearChoice.com had minor fluctuations. BioLifePlasma.com and 23andMe.com saw declines, with 23andMe.com dropping significantly.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Healthcare & Medical Biotech / Medical Equipment

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data

1
23andMe DNA Testing | Get Personalized DNA Insights https://www.23andme.com
Discover how your DNA can influence your health with insights backed by the latest science. Personalized genetic insights give you a more complete picture of your health. Services: 150+ Reports including:, Health...
2
BioLife Plasma Centers https://info.biolifeplasma.com › biolife › plasmaservices
Donate And Get Up To $750 — Register And Schedule An Appointment Online. Then Donate At A BioLife Center Near You.
3
CSL Plasma - Donation Centers - Get Up to $200 Your First Week https://www.cslplasma.com
Get up to $700 Your First Month. Compensation Varies by Location, and is Subject to Change
4
Inspire® therapy - No mask. No hose. Just sleep.™ https://www.inspiresleep.com
Discover an effective alternative to CPAP for treating sleep apnea. Learn more.
5
Dentist Near Me https://book.zocdoc.com › dentist › book-now
Find an In-Network Dentist — Book a Dentist in your area with availability that fits your schedule. Find the right Dentists for you based on location, insurance, reviews & more. In-Person & Online.

In the competitive landscape of Google PPC, 23andMe captivates with personalized DNA insights, while BioLife and CSL Plasma entice with lucrative donation offers. Inspire Sleep offers a CPAP alternative, and Zocdoc simplifies finding in-network dentists, each ad uniquely addressing health needs.

Frequently Asked Questions

Why are these reports useful and how should I use them?

Why these reports are useful

Imagine being able to instantly see your competitors Market Share, Share of Spend and their top performing ad copy so you can effectively benchmark your own performance.

Adthena’s PPC Market Share reports provide an instant view of performance insights across hundreds of sub-industries – so you can do just that.

How to use them
Think of these reports as a cheat sheet for your industry’s search landscape. Check out this short article for a breakdown of each report and how they can benefit your strategy.
How often is the data updated?

Data within the PPC Market Share Report 2025 is aggregated every month, highlighting the most significant changes from the previous period.
How does Adthena collect this data?

We use observed data from Google’s search results pages. With 20 million Google SERPs indexed per day. Adthena forms a global index of publicly available searches on Google.

On top of observed data, our data science models and patented technology expand on the insights through estimated metrics like market share, share of spend, and more.

We have 12 years of historical data across industries and our custom-built AI models learn from continuously updated data every day.
How accurate are these reports?

The PPC Marketing Share Report is powered by Adthena’s Whole Market View, which is the patented technology that drives value for our 300 enterprise customers.

Our unique approach to search intelligence ingests Google’s Keyword Planner into its learning models, providing a more accurate and up-to-date view of keyword data compared to traditional panel data methods.

With daily data collection and updates, Adthena offers a closer-to-real-time view of the Google Ads auction, enabling timely insights and adjustments.

Adthena focuses specifically on Google Ads, providing a deep dive into the channel and offering detailed insights into its workings. By processing 10 TB of new data daily and employing AI and machine learning models to analyze millions of Google Ads searches per second, Adthena provides a comprehensive and in-depth view of the competitive landscape.

Learn more about our data.

Learn more about our data accuracy
Does this include mobile, desktop and Google Shopping data?

Yes. The PPC Market Share Report 2025 aggregates data from across both device types and Google Shopping.
Who is this report for?

The PPC Market Share Report 2025 is for enterprise brands and agencies who want quick and high-level, historical benchmarks that are easily digestible and reveal insights, trends and market winners relevant to their own industry.
Can I get a custom report for my brand?

Our search consultants can introduce you to data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the geographies that need monitoring.

Complete the form below to get started.
What is Ask Arlo?

Ask Arlo leverages real-time GenAI to answer customers’ questions about their own search data and receive instant, tailored responses and reports directly within the Adthena platform.

With millions of Google SERPs indexed every day, Arlo never misses a trick and makes sure you’re always up to date.

Learn more about Ask Arlo.

Customer Success Stories

the7stars case study: Achieving Google Ads PPC campaign optimization with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance. Read case study

UNTUCKit Case Study: Retail brand unlocks $54k with Adthena’s Brand Activator

Discover how UNTUCKit optimized its brand search strategy using Adthena’s Brand Activator, resulting in $54k savings in just six months. Learn how they improved efficiency and competitor insights.Read case study

VodafoneZiggo case study: Boosting sales by 500% with a winning PPC strategy

VodafoneZiggo was looking to maximize revenue from its paid search campaigns while reducing costs and streamlining workflows. By leveraging Adthena’s data-driven insights and time-saving automation, the team gained full visibility into their ad spend performance and optimized budget allocation.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.

US Healthcare & Medical Biotech / Medical Equipment - PPC Market Share Analysis March 2025

Share of Clicks for top 10 US Healthcare & Medical Biotech / Medical Equipment brands

Share of Spend for the top 10 US Healthcare & Medical Biotech / Medical Equipment brands

Competitor Count for US Healthcare & Medical Biotech / Medical Equipment

Market Loss & Market Gains for US Healthcare & Medical Biotech / Medical Equipment

US Healthcare & Medical Biotech / Medical Equipment Share of Impressions

Google Text Ad Copy Insights & Creative Trends for US Healthcare & Medical Biotech / Medical Equipment

Frequently Asked Questions

Why are these reports useful and how should I use them?

Why these reports are useful

How often is the data updated?

How does Adthena collect this data?

How accurate are these reports?

Does this include mobile, desktop and Google Shopping data?

Who is this report for?

Can I get a custom report for my brand?

What is Ask Arlo?

Customer Success Stories

the7stars case study: Achieving Google Ads PPC campaign optimization​ with Adthena

UNTUCKit Case Study: Retail brand unlocks $54k with Adthena’s Brand Activator

VodafoneZiggo case study: Boosting sales by 500% with a winning PPC strategy

Get the full picture

See this data specific to your brand performance

the7stars case study: Achieving Google Ads PPC campaign optimization with Adthena